Exploring the Role of Surgery After Systemic Therapy in Locally Advanced Biliary Tract Cancer: Outcomes From a Large Retrospective Multinational Real-World Cohort Treated With Cisplatin, Gemcitabine, and Durvalumab

Gastrointestinal Cancer

The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine and durvalumab: a large real-life worldwide population

J Natl Cancer Inst

Rimini M, Fornaro L, Lo Prinzi F, Rizzato MD, Saborowski A, Antonuzzo L, Rossari F, Satake T, Peeters F, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Nichetti F, Jae Chon H, Braconi C, Qaisar A, Pirrone C, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Corallo S, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Alvim CM, Roque R, Farinea G, Salani F, De Rosa A, Lavacchi D, Camera S, Ikeda M, Dekervel J, Niger M, Balsano R, Tonini G, Kang M, Bekaii-Saab T, Esposito L, Boccaccino A, Himmelsbach V, Landriscina M, Djaballah SA, Zanuso V, Malapelle U, Pepe F, Masi G, Vogel A, Lonardi S, Rimassa L, Casadei-Gardini A

doi: 10.1093/jnci/djaf155

Gastrointestinal Cancer

Real-world outcomes of adjuvant therapy after curative-intent resection for biliary tract cancer

Eur J Cancer

Dong Y, Pereyra D, Podrascanin V, Li Z, Santol J, Ammann M, Hardy N, Kankeu Fonkoua LA, Graham RP, Conboy CB, Tran NH, Warner SG, Smoot RL, Starlinger PP

doi: 10.1016/j.ejca.2026.116887

Gastrointestinal Cancer

Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ-1 Study Eligibility: A Large Global Analysis in a Real-World Setting

Int J Cancer

Prinzi FL, Rimini M, Ikeda M, Abidoye O, Lucchetti J, Antonuzzo L, Kim JW, Nichetti F, Saborowski A, Pressiani T, Vivaldi C, Rapposelli IG, Peeters F, Braconi C, Pinato DJ, Tamburini E, Pircher C, Tamberi S, Castet F, Verrico M, Parisi A, Couto N, Chon HJ, Martirena A, Lamarca A, Landriscina M, Finkelmeier F, Oneda E, Avallone A, Dell'Aquila E, Perkhofer L, Kim IH, Formica V, de Sousa Pinto CM, Garajova I, Kang B, Corallo S, Fenocchio E, Farinea G, Pastorino A, Diana A, Changhoon Y, Schirripa M, Rodriquenz MG, Scartozzi M, Zumstein L, Ghidini M, Prager GW, Aprile G, Spinelli GP, Yung-Yeh S, Chan SL, Warmington E, Lancianese A, Satake T, Bekaii-Saab T, Giordano G, Lavacchi D, Passeri L, Ferrara M, Kang M, Prete AA, Bozzarelli S, Persano M, Masi G, Balsano R, Niger M, Lonardi S, Salani F, Camera S, Vogel A, Fornaro L, Rimassa L, Casadei-Gardini A

doi: 10.1002/ijc.70699

Skin Cancer

Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients

Eur J Cancer

Ugurel S, Abu Rached N, Gambichler T, Mengoni M, Tüting T, Hassel JC, Reschke R, Lodde GC, Placke JM, Schadendorf D, Reinhardt L, Kreuter A, Gschnell M, Utikal J, Erdmann M, Dücker P, Helbig D, Franklin C, Gebhardt C, Poch G, Kähler KC, Weichenthal M, Gutzmer R, Heinzerling L, Weishaupt C, Mohr P, Thoms KM, Lang B, Schilling B, Haferkamp S, Sachse M, Welzel J, Jochims F, Raap U, Schley G, Terheyden P, Dippel E, Pöttgen C, Becker JC, Tasdogan A, Amaral T, Nanz L, Leiter U

doi: 10.1016/j.ejca.2025.115750

Lung, Respiratory and Thoracic Cancer

Risk Factors Associated with Suboptimal Real-World Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Treated with Front-Line Recommended Therapy

Adv Ther

Spira AI, Ran T, Lin I, Chen C, He A, Belani N, Du S

doi: 10.1007/s12325-025-03234-3

Lymphoma

Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study

Br J Haematol

Porges T, Levi T, Dann EJ, Aumann S, Gurion R, Buchrits S, Perry C, Vitkon R, Levi I, Ilan E, Avigdor A, Marcus R, Harel R, Lahham N, Basood M, Filanovsky K, Dally N, Itchaki G, Sarid N, Benyamini N, Ben Barouch S, Tadmor T, Sofer O, Aboeid M, Strulovici A, Othman A, Kedmi M

doi: 10.1111/bjh.70682

Lung, Respiratory and Thoracic Cancer

Real-World Treatment Patterns and Clinical Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy and ≥ 2 Subsequent Lines of Therapy in the United States

Adv Ther

Sankar K, Unni S, Eberl M, Le H, Herrmann T, Gorsh B, Tang M, Coerts F, Ahmed S

doi: 10.1007/s12325-025-03408-z

Leukemia

Real-world treatment and outcomes in hairy cell leukemia: a multicenter retrospective cohort including BRAF inhibitor therapy

Leuk Lymphoma

Fradin JJ, Rein L, Szabo A, Carlson KS, Badar T, Holden T, Shah S, Im A, Patel AA, Atallah E

doi: 10.1080/10428194.2026.2684259

Gastrointestinal Cancer

Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy

Eur J Cancer

Benhima N, Audisio A, Gallio C, Ricco G, Meillat H, Velenik V, Riesco MC, Suárez Alecha J, Rasschaert G, Páez López-Bravo D, Tougeron D, Carvalho C, Borelli B, Famiglietti F, De la Pinta C, O'Connor JM, Artaç M, Braam PM, Puccini A, Waldhorn I, Vanden Bulcke A, Loi M, De Felice F, Eid M, Deleporte A, Rossini C, Montenegro P, Fiore M, Van Den Eynde M, Shamseddine A, Geboes KP, Messina M, Mulet Margalef N, Houlzé-Laroye C, Kirac I, Pastorino A, Salati M, Argalácsová S, Morano F, Capdevila J, Garajovà I, Antoun C, Sousa Pinto CM, Lutz MP, Adams RA, Chau A, Siebenhuener A, Dermine A, Ghidini M, Dulskas A, Papamichael D, Javed MA, Ruiz-Garcia E, Tomášek J, Petrillo A, Baratelli C, Vandamme T, Spolverato G, Bock F, Diaz M, Campana LG, Sur D, Karampeazis A, Patsko V, Puleo F, Bounedjar A, Fiorica F, Gilliaux Q, Bernardini I, De Stefano A, Grønlie Guren M, Jakubauskas M, Sert F, Gomez Galdon M, Veron Sanchez A, Vierasu OI, Assaf I, Moretti L, Martinive P, Liberale G, Van Laethem JL, Sclafani F, International Real-World TNT Study Consortium

doi: 10.1016/j.ejca.2026.116911

Related content

The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine and durvalumab: a large real-life worldwide population

Real-world outcomes of adjuvant therapy after curative-intent resection for biliary tract cancer

Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ-1 Study Eligibility: A Large Global Analysis in a Real-World Setting

Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients

Risk Factors Associated with Suboptimal Real-World Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Treated with Front-Line Recommended Therapy

Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study

Real-World Treatment Patterns and Clinical Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy and ≥ 2 Subsequent Lines of Therapy in the United States

Real-world treatment and outcomes in hairy cell leukemia: a multicenter retrospective cohort including BRAF inhibitor therapy

Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy